Ming-Jen Chen

Ming-Jen Chen

Auto-generated profile, based on publicly available information

Ming-Jen Chen

Department of Surgery, Mackay Memorial Hospital, Taipei, Taiwan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Journal of Breast Cancer
Verified
Journal Article
Open access
CLChien-Liang Liu
Chien-Liang Liu
MCMing-Jen Chen
Ming-Jen Chen
JLJiunn-Chang Lin
Jiunn-Chang Lin
CLChi-Hsin Lin
Chi-Hsin Lin
WHWen-Chien Huang
Wen-Chien Huang
YCYuan-Ching Chang
Yuan-Ching Chang
Liu CL, et al. J Breast Cancer. 2019 Mar;22:e22. https://doi.org/10.4048/jbc.2019.22.e22

13 May 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
CHChun-Te Ho
Chun-Te Ho
MWMei-Hsuan Wu
Mei-Hsuan Wu
MCMing-Jen Chen
Ming-Jen Chen
SLShih-Pei Lin
Shih-Pei Lin
YYYu-Ting Yen
Yu-Ting Yen
Shih-Chieh HungShih-Chieh Hung
Shih-Chieh Hung
Although oncolytic viruses are currently being evaluated for cancer treatment in clinical trials, systemic administration is hindered by many factors that prevent them from reaching the tumor cells. When administered systemically, mesenchymal stem cells (MSCs) target tumors, and therefore constitute good cell carriers for oncolytic viruses. MSCs were primed with trichostatin A under hypoxia, which upregulated the expression of CXCR4, a chemokine receptor involved in tumor tropism, and coxsackievirus and adenovirus receptor that plays an important role in adenoviral infection. After priming, MSCs were loaded with conditionally replicative adenovirus that exhibits limited proliferation in cells with a functional p53 pathway and encodes Escherichia coli nitroreductase (NTR) enzymes (CRAdNTR) for targeting tumor cells. Primed MSCs increased tumor tropism and susceptibility to adenoviral infection, and successfully protected CRAdNTR from neutralization by anti-adenovirus antibodies both in vitro and in vivo, and specifically targeted p53-deficient colorectal tumors when infused intravenously. Analyses of deproteinized tissues by UPLC-MS/QTOF revealed that these MSCs converted the co-administered prodrug CB1954 into cytotoxic metabolites, such as 4-hydroxylamine and 2-amine, inducing oncolysis and tumor growth inhibition without being toxic for the host vital organs. This study shows that the combination of oncolytic viruses delivered by MSCs with the activation of prodrugs is a new cancer treatment strategy that provides a new approach for the development of oncolytic viral therapy for various cancers.

25 May 2021 in Investigational New Drugs
Verified
Journal Article
Closed access
PDF file
JLJiunn-Chang Lin
Jiunn-Chang Lin
CLChien-Liang Liu
Chien-Liang Liu
YCYuan-Ching Chang
Yuan-Ching Chang
SCShih-Ping Cheng
Shih-Ping Cheng
WHWen-Chien Huang
Wen-Chien Huang
MCMing-Jen Chen
Ming-Jen Chen

Verified
Journal Article
Open access
PDF file
CLChien-Liang Liu
Chien-Liang Liu
WHWen-Chien Huang
Wen-Chien Huang
SCShih-Ping Cheng
Shih-Ping Cheng
MCMing-Jen Chen
Ming-Jen Chen
CLChi-Hsin Lin
Chi-Hsin Lin
YCYuan-Ching Chang
Yuan-Ching Chang
Among genetically engineered mouse models of breast cancer, MMTV-PyVT is a mouse strain in which the oncogenic polyoma virus middle T antigen is driven by the mouse mammary tumor virus promoter. The aim of the present study was to perform morphologic and genetic analyses of mammary tumors arising from MMTV-PyVT mice. To this end, mammary tumors were obtained at 6, 9, 12, and 16 weeks of age for histology and whole-mount analyses. We conducted whole-exome sequencing to identify constitutional and tumor-specific mutations, and genetic variants were identified using the GRCm38/mm10 mouse reference genome. Using hematoxylin and eosin analysis and whole-mount carmine alum staining, we demonstrated the progressive proliferation and invasion of mammary tumors. Frameshift insertions/deletions (indels) were noted in the Muc4. Mammary tumors showed small indels and nonsynonymous single-nucleotide variants but no somatic structural alterations or copy number variations. In summary, we validated MMTV-PyVT transgenic mice as a multistage model for mammary carcinoma development and progression. Our characterization may be used as a reference for guidance in future research.

24 June 2024 in Frontiers in Surgery
Verified
Journal Article
Open access
PDF file
PTPo-Li Tsai
Po-Li Tsai
JCJian-Syun Chen
Jian-Syun Chen
CLChi-Hsin Lin
Chi-Hsin Lin
THTzu-Chi Hsu
Tzu-Chi Hsu
YLYu-Wen Lin
Yu-Wen Lin
MCMing-Jen Chen
Ming-Jen Chen
Introduction: A mini-laparotomy for colorectal cancer (CRC) has been reported to shorten postoperative ileus (POI) and hospital stay. Interleukin-6 (IL-6) plays a role in intestinal tissue inflammation, leading to POI. This study investigated the effects of abdominal wounds and IL-6 levels on POI in patients having CRC surgery.Materials and methods: Forty-three patients with CRC underwent bowel resection. Serum samples were collected preoperatively and at 2, 24, and 48 h after surgery for cytokine quantification by ELISA. Clinical data, including time from surgery to first passage of flatus and postoperative hospital stay, demographic and pathological data, and routine blood tests, were compared statistically with abdominal wound length and the postoperative increments of cytokines (designated as Δ).Results: The length of the abdominal wound showed a significant correlation with clinical variables (length of operation time, time of first flatus passage, and length of postoperative hospital stay) and cytokine variables (IL-6(Δ2 h), IL-8(Δ2 h) and IL-10(Δ2 h). Linear regression analysis showed that the abdominal wound length significantly influenced the operation time, time of first flatus passage, and length of postoperative hospital stay (p < 0.001). The length of the abdominal wound showed a significant influence on the IL-6(Δ2 h) and IL-8(Δ2 h) (p < 0.001, respectively) but no influence on IL-10(Δ2 h). IL-6(Δ2 h), but not IL-8(Δ2 h), significantly influenced the time to first flatus passage and length of hospital stay (p = 0.007, p = 0.006, respectively). The mini-laparotomy approach (wound length <7 cm) led to significantly shortened operation time, time of first flatus passage, length of postoperative stay (p = 0.004, p = 0.003, p = 0.006, respectively) as well as reduced postoperative increment of IL-6(Δ2 h) (p = 0.015). The mini-laparotomy for anterior resection surgery significantly influenced operation time, time of first passage of flatus, length of postoperative stay, and IL-6(Δ2 h).Conclusion: Our study is the first to report the complex interaction among the length of the abdominal wound, IL-6 serum level, recovery of the first passage of flatus, and postoperative hospital stay. These results suggest that smaller abdominal wounds and smaller postoperative IL-6 increments were associated with faster recovery of flatus passage and shorter hospital stays.

1 January 2021 in Life Sciences
Verified
Journal Article
Closed access
CLChi-Hsin Lin
Chi-Hsin Lin
YCYuan-Ching Chang
Yuan-Ching Chang
TCTing-Kuo Chang
Ting-Kuo Chang
CHChang-Hung Huang
Chang-Hung Huang
YLYung-Chang Lu
Yung-Chang Lu
MCMing-Jen Chen
Ming-Jen Chen